Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (214)

2023

  1. Corrigendum: Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females (Front. Psychiatry, (2022), 13, 982583, 10.3389/fpsyt.2022.982583)

    Frontiers in Psychiatry

  2. Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents

    BMC psychiatry, Vol. 23, Núm. 1, pp. 178

  3. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort

    Psychiatry Research, Vol. 325

  4. Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder

    International Journal of Bipolar Disorders, Vol. 11, Núm. 1

  5. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients

    Revista de Psiquiatria y Salud Mental

  6. Incidence of mental disorders in the general population aged 1–30 years disaggregated by gender and socioeconomic status

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 6, pp. 961-971

  7. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode

    Psychological Medicine, Vol. 53, Núm. 10, pp. 4634-4647

  8. Lithium levels and lifestyle in patients with bipolar disorder: a new tool for self-management

    International Journal of Bipolar Disorders, Vol. 11, Núm. 1

  9. Mortality Risks after Two Years in Frail and Pre-Frail Older Adults Admitted to Hospital

    Journal of Clinical Medicine, Vol. 12, Núm. 9

  10. Obstetric complications and clinical presentation in first episode of psychosis

    Acta Neuropsychiatrica

  11. Predicting bipolar disorder I/II in individuals at clinical high-risk: Results from a systematic review

    Journal of Affective Disorders, Vol. 325, pp. 778-786

  12. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244